Scott L Burrows is Chief Financial Officer of Arcutis Biotherapeutics, Inc.. Currently has a direct ownership of 59,115 shares of ARQT, which is worth approximately $882,586. The most recent transaction as insider was on Mar 06, 2023, when has been sold 291 shares (Common Stock) at a price of $15.26 per share, resulting in proceeds of $4,440. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 59.1K
0% 3M change
0% 12M change
Total Value Held $882,586

Scott L Burrows Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 06 2023
SELL
Open market or private sale
$4,440 $15.26 p/Share
291 Reduced 0.49%
59,115 Common Stock
Mar 02 2023
SELL
Open market or private sale
$23,187 $16.17 p/Share
1,434 Reduced 3.6%
38,406 Common Stock
Mar 02 2023
BUY
Grant, award, or other acquisition
-
21,000 Added 26.12%
59,406 Common Stock
Feb 28 2023
SELL
Open market or private sale
$6,726 $16.17 p/Share
416 Reduced 1.03%
39,840 Common Stock
Sep 16 2022
BUY
Exercise of conversion of derivative security
$8,400 $1.68 p/Share
5,000 Added 11.05%
40,256 Common Stock
Mar 07 2022
SELL
Open market or private sale
$164 $16.44 p/Share
10 Reduced 0.03%
35,256 Common Stock
Mar 04 2022
SELL
Open market or private sale
$4,940 $16.86 p/Share
293 Reduced 0.82%
35,266 Common Stock
Mar 03 2022
BUY
Grant, award, or other acquisition
-
13,300 Added 27.22%
35,559 Common Stock
Mar 01 2022
SELL
Open market or private sale
$7,455 $17.75 p/Share
420 Reduced 1.85%
22,259 Common Stock
Dec 27 2021
SELL
Open market or private sale
$252,079 $20.07 p/Share
12,560 Reduced 35.64%
22,679 Common Stock

Also insider at

AGLE
Aeglea BioTherapeutics, Inc. Healthcare
SLB

Scott L Burrows

Chief Financial Officer
Westlake Village, CA

Track Institutional and Insider Activities on ARQT

Follow Arcutis Biotherapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ARQT shares.

Notify only if

Insider Trading

Get notified when an Arcutis Biotherapeutics, Inc. insider buys or sells ARQT shares.

Notify only if

News

Receive news related to Arcutis Biotherapeutics, Inc.

Track Activities on ARQT